Bionic three-dimensional tissue engineering scaffold and preparation method thereof
A tissue engineering scaffold, three-dimensional technology, applied in scaffolds, prostheses, medical science, etc., can solve the problem of low drug loading rate, and achieve the effect of improving loading rate and guiding regenerative function
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] (1) Dissolve 0.40 g of polycaprolactone (PCL, molecular weight: 60,000) in 3.5 ml of 1,2-dichloromethane and 0.5 ml of xylene, and drop into 20 microliters of Span with a pipette. After the PCL was completely dissolved under magnetic stirring, 250 microliters of active growth factor-rich PRP (containing 5% dextran as a protective agent) was added dropwise. Stir for 45 minutes under magnetic stirring. At the same time, gelatin (GE, molecular weight 100,000), fibroblast growth factor bFGFb, and endothelial cell growth factor VEGF were dissolved in trifluoroethanol to prepare a mixed solution with a total concentration of 12w / v%, wherein the active growth factor accounted for 0.05% of solids.
[0045] (2) Select a single nozzle spinning device, put the mixed solution of the PCL electrospun emulsion containing PRP, gelatin and active factor in step (1) into two different infusion channels respectively, and adjust the feeding rate of the solution to 20ul / min, the distance...
Embodiment 2
[0048] (1) Dissolve 0.40 g of polyglycolide (PLGA, molecular weight: 100,000) in 8 mL of chloroform, and drop into 50 microliters of Span 80 with a pipette. After the PLGA was completely dissolved under magnetic stirring, 250 microliters of PRP (containing 5% dextran as a protective agent) was added dropwise. Stir for 45 minutes under magnetic stirring. At the same time, gelatin (GE, molecular weight 100,000), hyaluronic acid (HA, molecular weight 500,000), fibroblast growth factor bFGFb, and endothelial cell growth factor VEGF were dissolved in a mixed solvent with a volume ratio of DMF and water of 1:1. The fixed hyaluronic acid concentration is 1%, the mass ratio of hyaluronic acid and gelatin is 100:20, and the active molecule accounts for 0.08% of the solid content.
[0049] (2) Select a single-nozzle spinning device, put the mixed solution of the PLGA electrospun emulsion containing PRP and gelatin / hyaluronic acid / active factor in step (1) into two different infusion ch...
Embodiment 3
[0052] (1) Polyethylene lactide (PLGA, molecular weight 80,000) was dissolved in 8 mL of chloroform, and 50 microliters of Span 80 was dropped into it with a pipette gun. After the PLGA was completely dissolved under magnetic stirring, 250 microliters of PRP (containing 5% dextran as a protective agent) was added dropwise. Stir for 45 minutes under magnetic stirring. At the same time, gelatin (GE, molecular weight 100,000) was dissolved in a mixed solvent with a volume ratio of water and ethanol of 9:1 to prepare a mixed solution with a total concentration of 15w / v%.
[0053](2) select double-nozzle spinning device for use, the PLGA solution of step (1) and the GE mixed solution containing active molecules are respectively packed in two different infusion pathways, and the feeding rate of the adjustment solution is 15ul / min, and the spinning The distance between the head and the grounded collector is 12cm; the ambient temperature is 25°C; the electrostatic voltage of PLGA ele...
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com